QPS Qualitix Taiwan is a Contract Research Organization and Site Management Organization offering high quality, cost effective research development services to assist clients in the pharmaceutical, biotechnology and medical device industries. It has one of the broadest ranges of product development, clinical research, and regulatory services in Taiwan. Together with its strong Asia-Pacific regional network of CRO partners in the Asia-Pacific region, QPS Qualitix Taiwan acts as an attractive launching point from which clients may address the rapidly growing Asian market. QPS Qualitix Taiwan also owns a subsidiary corporation called Unitix – a site management organization which affords QPS Qualitix Taiwan to have the unique advantage of speedy patient recruitment in the region.
QPS Qualitix Taiwan has an established network of prominent Taiwanese investigators at all 22 medical centers in Taiwan. It is the largest local CRO with broad clinical trial expertise, handling IND trials mainly focused on oncology and metabolic disorders in Taiwan, for global filing. The depth and breadth of QPS Qualitix Taiwan’s experience in this important therapeutic field attracts major clients and partners including global pharmaceutical clients as well as local pharmaceutical and biotech clients from the Asia-Pacific region.